XML 33 R21.htm IDEA: XBRL DOCUMENT v3.25.1
OTHER EXPENSE, NET
 3 Months Ended
Mar. 31, 2025
Other Income and Expenses [Abstract]  
OTHER EXPENSE, NET OTHER EXPENSE, NET
Other expense, net consists of:
Three Months Ended March 31,
(in millions)20252024
Acquired in-process research and development costs$28 $— 
Acquisition-related transaction costs1 — 
Litigation and other matters, net of insurance recoveries and restitutions(3)6 
Acquisition-related contingent consideration(11)(2)
Gain on sale of assets, net— (4)
$15 $— 
Acquired in-process research and development costs for the three months ended March 31, 2025 are related to Bausch + Lomb’s acquisition of Whitecap Biosciences.
Acquisition-related contingent consideration for the three months ended March 31, 2025 and 2024 reflects adjustments for changes in estimates in the timing and amounts of expected future royalty and milestone payments and accretion for the time value of money.
For the three months ended March 31, 2025, Litigation and other matters primarily relates to restitution received in connection with a certain legal matter. For the three months ended March 31, 2024, Litigation and other matters primarily related to adjustments to provisions for certain legal matters.